DETECTION OF LUNG CANCER USING CELL-FREE DNA FRAGMENTATION

Cell free DNA (cfDNA) fragmentation for lung cancer detection is combined with current imaging-based screening methods and biomarkers. La fragmentation d'ADN acellulaire (DNAcf) pour la détection du cancer du poumon est combinée à des méthodes actuelles de dépistage basées sur une imagerie et d...

Full description

Saved in:
Bibliographic Details
Main Authors BRUHM, DANIEL, VELCULESCU, VICTOR, CRISTIANO, STEPHEN, MATHIOS, DIMITRIOS, PHALLEN, JILLIAN A, SCHARPF, ROBERT B
Format Patent
LanguageEnglish
French
Published 30.06.2022
Subjects
BEER
BIOCHEMISTRY
CALCULATING
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
COMPUTER SYSTEMS BASED ON SPECIFIC COMPUTATIONAL MODELS
COMPUTING
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
COUNTING
ENZYMOLOGY
INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PHYSICS
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Cell free DNA (cfDNA) fragmentation for lung cancer detection is combined with current imaging-based screening methods and biomarkers. La fragmentation d'ADN acellulaire (DNAcf) pour la détection du cancer du poumon est combinée à des méthodes actuelles de dépistage basées sur une imagerie et des biomarqueurs.
Bibliography:Application Number: CA20213200565